Mineralocorticoid receptors and cardiovascular damage - It's not just aldosterone

被引：35

作者：

Funder, JW ^{[1
]}

机构：

[1] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia

来源：

HYPERTENSION | 2006年 / 47卷 / 04期

关键词：

D O I：

10.1161/01.HYP.0000203732.03784.3b

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：634 / 635

页数：2

共 12 条

[1] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR [J].

ARRIZA, JL ;

WEINBERGER, C ;

CERELLI, G ;

GLASER, TM ;

HANDELIN, BL ;

HOUSMAN, DE ;

EVANS, RM .

SCIENCE, 1987, 237 (4812) :268-275

[2]

BRILLA CG, 1992, J LAB CLIN MED, V120, P893

[3] Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: In vivo binding studies [J].

Funder, J ;

Myles, K .

ENDOCRINOLOGY, 1996, 137 (12) :5264-5268

[4] Is aldosterone bad for the heart? [J].

Funder, JW .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (04) :139-142

[5]

HU X, 2005, MOL ENDOCRINOL 0929

[6] Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats [J].

Nagata, K ;

Obata, K ;

Xu, JL ;

Ichihara, S ;

Noda, A ;

Kimata, H ;

Kato, T ;

Izawa, H ;

Murohara, T ;

Yokota, M .

HYPERTENSION, 2006, 47 (04) :656-664

[7] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].

Pitt, B ;

Remme, W ;

Zannad, F ;

Neaton, J ;

Martinez, F ;

Roniker, B ;

Bittman, R ;

Hurley, S ;

Kleiman, J ;

Gatlin, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321

[8] Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy - The 4E-left ventricular hypertrophy study [J].

Pitt, B ;

Reichek, N ;

Willenbrock, R ;

Zannad, F ;

Phillips, RA ;

Roniker, B ;

Kleiman, J ;

Krause, S ;

Burns, D ;

Williams, GH .

CIRCULATION, 2003, 108 (15) :1831-1838

[9] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[10] Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart [J].

Rocha, R ;

Martin-Berger, CL ;

Yang, PC ;

Scherrer, R ;

Delyani, J ;

McMahon, E .

ENDOCRINOLOGY, 2002, 143 (12) :4828-4836

← 1 2 →